Fiscal Wizard · Single-issue tearsheet

IDXX / May 12, 2026 Run #8

IDXX

IDEXX Laboratories, Inc.

Diagnostics & Research

Composite verdict

F 29.6 / 100

Above-average fundamentals, weak technicals.

Industry rank 6th of 14 in Diagnostics & Research

industry=Diagnostics & Research

Fundamentals Above average

59.1 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 34 metrics shown.

Strongest
Weakest
EBITDA Margin 100
Forward P/E 0
FCF Margin 100
EV/FCF 0
Greenblatt ROC 100
Earnings Yield 0

Technicals Weak

0.0 / 100

Bearish setup leads (Relative Strength vs SPY, Fibonacci Retracement, Multi Top/Bottom); bulls voided by gates. · 26 signals shown.

Strongest
Weakest
Star 50
Relative Strength vs SPY 0
Donchian Breakout 49
Fibonacci Retracement 0
Ichimoku 31
MA Rejection 3

Risk Gates

2 blocking 2 caution

2 gates blocking, 13 signals voided.

  • MA Crossover voids RSI Divergence, MACD Divergence +11
  • Regime Filter voids RSI Divergence, MACD Divergence +11
  • Cash Ratio caution band
  • Current Ratio caution band

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for IDXX.